ComprehensiveOffering Provides Flexible Access to Key Quality Processes
Sparta Systems, Inc., an industry pioneer and global leader in enterprise quality management software (EQMS) solutions, today announced the availability of a comprehensive mobile solution product suite designed to improve the operational efficiency and effectiveness of its customers’ increasingly mobile workforce. Organizations are now able to significantly expand the reach of their quality processes, reporting and analytics beyond the four walls of their businesses.
Sparta Systems’ mobile product suite includes:
These Sparta Systems’ mobile offerings provide the following business and usability benefits:
“The launch of Sparta System’s mobile product suite underscores our continued commitment and investment in our customers,” said Eileen Martinson, Chief Executive Officer. “The entirely reinvented mobile user experience, combined with delivery as a turnkey service will rapidly accelerate customers’ time to adoption and realization of value.”
TrackWise Mobile product suite has been optimized to work on most Apple iOS devices, with support for Android devices expected later this quarter. To learn more view the TrackWise Mobile video or visit www.spartasystems.com.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.